Warm-toned photograph of a stethoscope resting on a wooden desk beside medical charts, conveying a serious healthcare setting

A national public affairs campaign launched by the American College of Cardiology in December 2009 to oppose Medicare physician fee schedule cuts affecting cardiology patients and practices.

About the Campaign

The Campaign for Patient Access was launched by the American College of Cardiology in December 2009 as a national effort to reverse Medicare physician fee schedule cuts that threatened cardiovascular care. The site provided background on the issue, the ACC's legislative and legal response, resources for patients and practices, a newsroom tracking coverage across the country, and ways for supporters to share their stories and support the campaign.

From the Newsroom

Capitol building dome against a pale sky, conveying federal policy and legislative action
April 30, 2010

Medicare Meltdown: Access to Health Care in "Critical Condition"

A press release warning that cardiology access was in critical condition due to Medicare payment cuts.

Read more
Gavel on a dark wooden bench in a courtroom setting, suggesting legal proceedings
December 29, 2009

Cardiology Takes Legal Action Against Medicare

The ACC filed suit against HHS Secretary Kathleen Sebelius over the 2010 Physician Fee Schedule.

Read more
A stack of newspapers with a muted gray and off-white palette, suggesting breaking health policy news
January 12, 2010

ACC Statement on Health Care Reform

The ACC used the State of the Union address to highlight the need to reverse the Medicare cuts.

Read more
A wide shot of a diverse group of healthcare professionals and advocates gathered around a conference table, deep in discussion
April 12, 2010

Medicare Patients and Physicians Join Petition Drive

Patients and physicians in Washington, DC joined a petition drive calling on Congress for Medicare reform.

Read more

How Payment Cuts Threaten Cardiac Genetic Care

Cardiac genetic testing and counseling can reveal why a person developed an inherited heart condition and which relatives may also face danger. For families affected by hypertrophic cardiomyopathy, long QT syndrome, arrhythmogenic cardiomyopathy, familial hypercholesterolemia, or other hereditary disorders, this information can guide screening, treatment, and decisions about activity or pregnancy.

The effect of cuts on access to cardiac genetic testing and counseling is easy to overlook because these services may appear to be specialized or optional. In practice, they are often part of a larger care pathway that can prevent sudden cardiac death, reduce unnecessary procedures, and help clinicians select appropriate surveillance for several generations of a family.

When Medicare reimbursement declines while staffing, laboratory, technology, and compliance costs rise, cardiology practices must make difficult choices. The impact may appear as a longer wait for an appointment, fewer genetic counselors, reduced help with insurance authorization, or the loss of testing services in a local community.

Why genetic information matters in cardiac care

Inherited cardiovascular disease often does not follow a simple pattern. A patient may have few symptoms before a dangerous arrhythmia, while a sibling or child carries the same variant with a different level of risk. A carefully obtained family history, clinical evaluation, and genetic test can connect these details and help a care team identify people who need earlier monitoring.

Testing is most useful when it is paired with professional counseling. A counselor can explain what a positive, negative, or uncertain result means, discuss limitations of the test, and help relatives decide whether targeted testing is appropriate. This context reduces misinterpretation and prevents families from treating a genetic result as a standalone diagnosis.

Results can influence choices such as electrocardiographic monitoring, cardiac imaging, medication, referral for an implantable device, or evaluation by a specialized inherited heart disease clinic. They may also clarify whether relatives need intensive follow-up or can avoid unnecessary testing. Delays therefore carry clinical and emotional costs, even when the initial appointment seems routine.

How reimbursement pressure disrupts the care pathway

Genetic evaluation requires time that is difficult to capture in a brief office visit. Clinicians may review several generations of family history, collect records from relatives, assess informed consent, coordinate a laboratory, and interpret results after testing. Counseling often involves a separate conversation once the report is available. Fee schedule reductions can make this work financially unsustainable when payment does not reflect the complexity involved.

A practice facing lower physician reimbursement may reduce appointments that require extensive counseling or shift staff toward services with more predictable payment. Genetic counselors, nurse coordinators, and other specialists can be particularly vulnerable because their work may be billed indirectly or not fully reimbursed. If a position is eliminated, a cardiologist may have to absorb the work, refer patients elsewhere, or limit the number of families seen.

Administrative friction adds another burden. Prior authorization, documentation, variant interpretation, and communication with laboratories all require staff time. When a clinic operates with fewer people, these tasks can slow the process from referral to result. A patient who should be tested promptly may wait months before a complete evaluation is arranged.

Where patients feel the effects first

Access problems frequently begin with geography. Large academic hospitals may retain inherited cardiomyopathy programs, while smaller hospitals and independent practices may lack genetic counselors or cardiologists with specialized training. Patients in rural areas can face long drives, missed work, transportation expenses, and the additional challenge of finding a clinician who accepts Medicare or their commercial insurance.

Affordability also shapes whether a referral becomes completed care. Even when the laboratory offers financial assistance, patients may worry about consultation charges, follow-up visits, travel, or time away from work. Coverage rules can vary according to the test, the suspected condition, the ordering clinician, and the patient’s plan. Confusing or unpredictable costs can cause families to postpone testing until a serious event occurs.

Disparities may widen when language access and culturally responsive counseling are limited. Genetic concepts are complex in any setting, and communication barriers can make consent and result interpretation harder. A payment environment that supports adequate staffing gives practices more capacity to provide interpreters, care coordination, and follow-up rather than treating each test as a single transaction.

Point in care Effect of inadequate support Potential consequence
Referral and risk assessment Fewer specialist appointments and less time for family-history review Inherited disease may remain unrecognized
Pre-test counseling Reduced access to trained counseling staff Patients may proceed without understanding benefits and limitations
Laboratory coordination Delays with authorization, specimen collection, or paperwork Testing and treatment decisions are postponed
Result interpretation Less time to explain variants and implications for relatives Anxiety, confusion, or inappropriate screening may follow
Cascade testing Limited outreach to at-risk family members Relatives who could benefit from early care remain unidentified
Long-term follow-up Fragmented communication between primary care and cardiology Important changes in risk may be missed

The consequences for families and clinical teams

A delayed genetic evaluation can create a chain reaction. A patient may continue receiving general cardiac care without a clear explanation for recurrent fainting, an enlarged heart, high cholesterol, or unexplained rhythm disturbances. Relatives may remain unaware that they should seek screening. In some conditions, the missed opportunity is measured in years rather than days.

The effect is also felt by clinicians. Cardiologists who lack adequate support may spend uncompensated hours interpreting reports, contacting relatives, and coordinating referrals. Primary care physicians may receive results without clear guidance about their significance. This fragmentation can lead to duplicated testing, inconsistent surveillance, and avoidable referrals to emergency care.

Early identification can be economically meaningful as well as clinically valuable. Appropriate monitoring may detect disease before a crisis, while accurate family screening can focus resources on people who need them. If access cuts push care toward emergency departments and late-stage treatment, short-term savings in physician payment may contribute to higher costs elsewhere in the health system.

Access varies by practice and community

The same reimbursement change can have different effects depending on a practice’s size and resources. An integrated health system may be able to subsidize genetic counseling, maintain a multidisciplinary clinic, or use telehealth to reach distant patients. A small cardiology office may have no comparable reserve and may stop offering counseling or refer every case to a distant center.

Telehealth can help with education, result disclosure, and family communication, but it does not solve every access problem. Patients may still need an in-person examination, an electrocardiogram, imaging, or a blood sample. Reliable broadband, private space, digital literacy, and state licensing rules also influence whether virtual care is practical.

Laboratory partnerships and remote counseling networks can extend reach, yet quality depends on coordination. Patients need a clinician who can connect the genetic result to their personal history and cardiac findings. Payment policy should recognize that testing without interpretation and follow-up is an incomplete service.

Practical steps for protecting continuity of care

Practices can reduce avoidable delays while broader payment policy is addressed. Clear referral criteria, standardized family-history forms, and shared documentation can help teams identify high-risk patients early. Partnerships with specialized centers may give community clinicians access to expert interpretation without requiring every family to travel for every visit.

Patients and relatives can also prepare useful information before an appointment, including medical records, death certificates when available, details about sudden deaths, and known genetic results in the family. This does not replace professional counseling, but it can make limited clinical time more productive and reduce repeated requests for information.

Useful actions for care teams and advocates include:

  • Track referrals from initial risk assessment through result disclosure and follow-up.
  • Build relationships with genetic counselors, laboratories, and inherited heart disease centers.
  • Use plain-language materials and qualified interpreters for consent and result discussions.
  • Document the time and staffing required for family-history review, counseling, and cascade testing.
  • Share real patient experiences when payment policies threaten local cardiovascular services.

Why payment policy is an access issue

Physician fee schedule decisions are often discussed as financial policy, but their consequences reach the exam room. When reimbursement fails to support complex cardiovascular evaluation, practices may narrow their services, reduce staff, or avoid patients whose care requires substantial coordination. Cardiac genetics is especially sensitive because its value emerges across time and across family members, while payment is often tied to individual encounters.

A durable approach should recognize the full pathway: identifying a possible inherited condition, obtaining informed consent, ordering an appropriate panel, interpreting the report, counseling relatives, and maintaining surveillance. Payment models that support this work can help preserve local expertise and reduce the concentration of care in a few urban centers.

The patient access campaign provides a place to follow policy developments and understand how physician payment decisions affect the availability of cardiovascular services. Patients, physicians, and families can use credible information and personal stories to show why access to specialized evaluation should not depend solely on geography or a practice’s ability to absorb losses.

Preserving cardiac genetic testing and counseling requires attention before a patient experiences a preventable crisis. Contact elected representatives, share documented experiences with professional and patient advocacy organizations, and ask local cardiology practices how families can obtain timely evaluation. When communities make the connection between reimbursement and inherited heart disease care visible, decision-makers have stronger evidence for protecting the services that keep patients and relatives safer.

A close-up of a handwritten letter on paper beside a pen, warm natural light, soft cream and muted gray tones

Share Your Story

Tell us how Medicare cuts affected access to cardiovascular care. Stories could be reviewed and submitted to local news outlets as part of the campaign's outreach.